cbdMD, Inc. (YCBD)

Market Cap	2.89M
Revenue (ttm)	19.48M
Net Income (ttm)	-7.70M
Shares Out	5.54M
EPS (ttm)	-1.79
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Open	0.521
Previous Close	0.516
Day's Range	0.495 - 0.522
52-Week Range	0.311 - 1.340
Beta	2.03
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 11, 2025

About YCBD

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solution...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2015
• Employees: 42
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: YCBD
• Website: https://www.cbdmd.com

Financial Performance

In 2024, cbdMD's revenue was $19.48 million, a decrease of -19.35% compared to the previous year's $24.16 million. Losses were -$7.70 million, -71.40% less than in 2023.